Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists
In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting
FDA Pettiness Holds Up Trials with Promising Anticancer Drugs
FDA Proposes Guidelines For Testing New Anticancer Drugs
Breast Cancer Progress Report Summaries
Shubick Committee Support New System for NCU Review, Action On Chemicals
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - What happened at FDA? Replimune approval raises questions









